Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
about
Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancerReporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingEvolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancerThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesionsValidation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analysesUBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Prognostic significance of PLIN1 expression in human breast cancer.Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables.The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.Prognostic genes of breast cancer revealed by gene co-expression network analysis.Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer.The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients.Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B proteinIdentification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics AnalysisLooking beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer
P2860
Q27853207-689CC1D0-1955-4560-9D50-24D854EF4A6CQ28539229-D6A6E7D3-89AA-454C-A1A4-7DCB893E0221Q30514241-599A921C-0A2A-473A-97AB-973FE35E70D0Q30858189-9634A60E-0D3C-4B2C-9A56-55436EC1C49CQ30938412-ABBD32B4-32EE-4B67-9C96-DE5B2C03150FQ30978083-5F9E0515-57BD-46E3-9E89-12C77C3FDF02Q31157579-25A79160-3B71-4F93-A30C-CDF293B2B2D2Q34013059-392C733E-7202-4C65-9BC0-378120ED3D94Q36543286-F0CA543D-1421-40D9-8F06-1F72649E0B59Q36956211-7C29CCD9-23BC-42C2-854D-C9E589E2EE1AQ37688087-619A7C13-07E9-4974-ABDB-F458FA5D3525Q38891828-2CB03586-8CDD-4716-9BAD-1478548DB08DQ39331942-D601CE76-C2B7-44D1-AE77-526E7EA9BC4AQ39540207-3539BE48-AD2D-4C8A-87C0-C35C415D18BCQ41132483-1D8050BD-50DA-451C-8597-CE00DE7FB66FQ42363904-EB9011D4-7823-4EA1-A484-43370C20163AQ47095948-FF3A8330-0B27-4BBE-A3D8-807582B0D4F3Q47248494-7F47F1DE-E9FC-4D8F-B36A-03F69C54C4DFQ53013674-D5F115C9-34FD-4AA0-B9BC-46DE91C3BC95Q53175932-4EBDD904-583D-4791-A3B0-FB8A72A82509Q54241791-DF759C3D-8438-47DF-9011-C7A8E5C233CAQ58100438-613FDA20-4140-43C3-B8D5-3E7D54BB161EQ58122535-D685CD90-42AA-46C1-B5AF-CC8284F70BA7Q59051399-0B0E19FE-A70D-4912-A8AD-1D2CB4D7427B
P2860
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@en
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@nl
type
label
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@en
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@nl
prefLabel
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@en
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@nl
P2093
P2860
P356
P1476
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
@en
P2093
C Charbonnel
D Loussouarn
G Ricolleau
P Jézéquel
R Bataille
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605122
P407
P50
P577
2009-06-09T00:00:00Z